Insider Transactions in Q1 2022 at Homology Medicines, Inc. (FIXX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2022
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
5,354
-5.86%
|
$16,062
$3.78 P/Share
|
|
Jan 05
2022
|
Gabriel Cohn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,661
-38.72%
|
$4,983
$3.78 P/Share
|
|
Jan 05
2022
|
Albert Seymour |
SELL
Open market or private sale
|
Direct |
1,661
-1.25%
|
$4,983
$3.78 P/Share
|
|
Jan 05
2022
|
Timothy P Kelly Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,406
-38.73%
|
$4,218
$3.78 P/Share
|
|
Jan 05
2022
|
W Bradford Smith Officer |
SELL
Open market or private sale
|
Direct |
2,182
-33.06%
|
$6,546
$3.78 P/Share
|
|
Jan 01
2022
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
13,860
+13.17%
|
-
|
|
Jan 01
2022
|
Gabriel Cohn Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,290
+50.0%
|
-
|
|
Jan 01
2022
|
Albert Seymour |
BUY
Exercise of conversion of derivative security
|
Direct |
4,290
+3.12%
|
-
|
|
Jan 01
2022
|
Timothy P Kelly Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,630
+50.0%
|
-
|
|
Jan 01
2022
|
W Bradford Smith Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+50.0%
|
-
|